BIOCYTOGEN-B (02315) Plans to Use Idle Own Funds for Cash Management

Stock News01-28

BIOCYTOGEN-B (02315) announced that to enhance the efficiency of its own capital utilization, the company intends to reasonably use a portion of its idle own funds for cash management, provided that it does not affect normal production and operations and ensures the safety of the funds. This initiative can improve the efficiency of capital use, increase returns on the company's cash assets, and secure more investment returns for the company and its shareholders. The company plans to use up to RMB 500 million (inclusive) in temporarily idle own funds for cash management. Within the aforementioned limit, the funds can be recycled and rolled over for use. The company intends to use the temporarily idle own funds to purchase wealth management products issued by banks and other financial institutions that are characterized by high security, good liquidity, and low risk for entrusted financial management.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1164294401?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-28 08:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1164294401","market":"hk","top_or_hot":-1,"title":"BIOCYTOGEN-B (02315) Plans to Use Idle Own Funds for Cash Management","media":"Stock News","content":"<p>BIOCYTOGEN-B (02315) announced that to enhance the efficiency of its own capital utilization, the company intends to reasonably use a portion of its idle own funds for cash management, provided that it does not affect normal production and operations and ensures the safety of the funds. This initiative can improve the efficiency of capital use, increase returns on the company's cash assets, and secure more investment returns for the company and its shareholders. The company plans to use up to RMB 500 million (inclusive) in temporarily idle own funds for cash management. Within the aforementioned limit, the funds can be recycled and rolled over for use. The company intends to use the temporarily idle own funds to purchase wealth management products issued by banks and other financial institutions that are characterized by high security, good liquidity, and low risk for entrusted financial management.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BIOCYTOGEN-B (02315) Plans to Use Idle Own Funds for Cash Management</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBIOCYTOGEN-B (02315) Plans to Use Idle Own Funds for Cash Management\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-01-28 08:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BIOCYTOGEN-B (02315) announced that to enhance the efficiency of its own capital utilization, the company intends to reasonably use a portion of its idle own funds for cash management, provided that it does not affect normal production and operations and ensures the safety of the funds. This initiative can improve the efficiency of capital use, increase returns on the company's cash assets, and secure more investment returns for the company and its shareholders. The company plans to use up to RMB 500 million (inclusive) in temporarily idle own funds for cash management. Within the aforementioned limit, the funds can be recycled and rolled over for use. The company intends to use the temporarily idle own funds to purchase wealth management products issued by banks and other financial institutions that are characterized by high security, good liquidity, and low risk for entrusted financial management.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1164294401","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1164294401","pubTimestamp":1769559015,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"BIOCYTOGEN-B (02315) announced that to enhance the efficiency of its own capital utilization, the company intends to reasonably use a portion of its idle own funds for cash management, provided that...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688796":"百奥赛图","BK1161":"生物科技","BK0216":"研究试验","02315":"百奥赛图-B"},"translate_title":"百奥赛图-B(02315)拟使用闲置自有资金进行现金管理","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688796":1,"02315":1},"content_text":"BIOCYTOGEN-B (02315) announced that to enhance the efficiency of its own capital utilization, the company intends to reasonably use a portion of its idle own funds for cash management, provided that it does not affect normal production and operations and ensures the safety of the funds. This initiative can improve the efficiency of capital use, increase returns on the company's cash assets, and secure more investment returns for the company and its shareholders. The company plans to use up to RMB 500 million (inclusive) in temporarily idle own funds for cash management. Within the aforementioned limit, the funds can be recycled and rolled over for use. The company intends to use the temporarily idle own funds to purchase wealth management products issued by banks and other financial institutions that are characterized by high security, good liquidity, and low risk for entrusted financial management.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1164294401","isCrawlerRequest":true}